Figure 3.
Risk-benefit analysis for maintenance therapy post-allogeneic stem cell transplant. MRD, measurable residual disease; GVHD, graft versus host disease.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.